| Identification | More | [Name]
Calcifediol | [CAS]
63283-36-3 | [Synonyms]
25-HYDROXYCHOLECALCIFEROL
25-hydroxycholecalciferol monohydrate
25-HYDROXYVITAMIN D3
25-hydroxyvitamin d3 monohydrate
25-OH-D3
(5z,7e)-9,10-secocholesta-5,7,10(19)-triene-3b,25-diol monohydrate
CALCIDIOL
CALCIFEDIOL
CALCIFEDIOL MONOHYDRATE
VITAMIN D3, 25-HYDROXY-
CALCIFEDIOL 1-HYDRATE
9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, monohydrate, (3.beta.,5Z,7E)-
Calcifediol hydrate | [EINECS(EC#)]
242-990-9 | [Molecular Formula]
C27H44O2 | [MDL Number]
MFCD00867077 | [Molecular Weight]
400.64 | [MOL File]
63283-36-3.mol |
| Chemical Properties | Back Directory | [Appearance]
White or almost white crystals. | [Fp ]
14℃ | [storage temp. ]
−20°C
| [solubility ]
Practically insoluble in water, freely soluble in ethanol (96 per cent), soluble in fatty oils. | [form ]
neat | [color ]
White to Light yellow | [BRN ]
4270041 | [InChIKey]
JWUBBDSIWDLEOM-LCDSLSDMSA-N | [SMILES]
C[C@]12CCC/C(=C\C=C3\C[C@@H](O)CCC\3=C)/[C@]1([H])CC[C@]2([H])[C@H](C)CCCC(O)(C)C.O |&1:1,10,16,20,22,r| | [CAS DataBase Reference]
63283-36-3(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
T+ | [Risk Statements ]
R28:Very Toxic if swallowed. | [Safety Statements ]
S28:After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer) .
S36/37:Wear suitable protective clothing and gloves .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [RIDADR ]
UN 2811 6.1/PG 2
| [WGK Germany ]
3
| [F ]
8-10-19 | [HS Code ]
29362900 |
| Hazard Information | Back Directory | [Chemical Properties]
White or almost white crystals. | [Uses]
Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 μM. It is produced in the liver and is the best indicator of the body’s vitamin D stores. It is effective in the treatment of ricket | [Definition]
ChEBI: Calcifediol monohydrate is a vitamin D. | [Brand name]
Calderol (Organon). | [General Description]
A Certified Spiking Solution? of 25-Hydroxyvitamin D3, a prohormone whose blood serum levels are used to determine Vitamin D nutritional status. This solution standard is suitable for critical quantitative applications in research and clinical environments including: for use in preparation of controls and calibrators for LC/UV and LC-MS/MS assays; as system tuning/suitability standards; linearity verification; internal proficiency testing; and for OEM use in preparation of reagents, development of assays and instrument IQ/OQ. The stable, quantitative solution format provides significant benefits to the user including material savings, increased efficiency of labor, and convenience of use. The shelf stable Snap-N-Spike? format allows laboratories to eliminate painstaking weighing operations and provides the ability to spike a known concentration of analyte into their matrix of choice just before use. | [Biochem/physiol Actions]
Cholecalciferol is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs. 1α-Hydroxyvitamin D3 (alfacalcidol) is a synthetic analog that is metabolized to 1,25-dihydroxycholecalciferol, the biologically active form of vitamin D3. Other analogues of cholecalciferol result from different hydroxylations. 25-dihydroxycholecalciferol is a the major circulating form of vitamin D3 and a physiological precursor of 1α,25-Dihydroxycholecalciferol. The conversion is catalyzed by 25-Hydroxyvitamin D3 1-α-hydroxylase (VD3 1A hydroxylase) also known ascytochrome p450 27B1 (CYP27B1). | [target]
IL Receptor | [Dosage]
Calcidiol monohydrate contains the monohydrate form of the major circulating metabolite of vitamin D3 in the body and is a source of 1,25-dihydroxyvitamin D, the biologically active form of vitamin D. Calciferol monohydrate (25-hydroxycholecalciferol monohydrate) is safe under recommended conditions and level of use (up to 10 μg/day) and is safe for children >11 years of age and adults, including pregnant and lactating women. |
|
|